Outcomes of Anti Stigma Educational Intervention of Ungraduated Medical Students

NCT05596305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-10-27

No results posted yet for this study

Summary

Background: Stigma causes a significant burden for mental ill patients. Unfortunately, negative attitudes towards mentally ill are not confined to the lay public but are also common among health professionals.

Aim: To study outcomes of psychiatric anti stigma educational intervention on undergraduate medical students' knowledge, attitude, and behavior as primary outcome measures.

Subjects and methods: a quasi-experimental study was conducted on fourth year (120) undergraduate medical students affiliated to faculty of Medicine-Suez Canal University. The participants conducted a semi-structured questionnaire to assess effect of anti-stigma program on their knowledge, attitude and intended behavior toward mentally ill. The participants completed baseline questionnaire, then immediately and after 6 months reassessment. Data was collected from November 2019 to May 2020.

Conditions

  • Stigmatization
  • Medical Education

Interventions

BEHAVIORAL

educational psychiatry intervention

educational anti-stigma intervention related to psychiatric illness composed of a lecture, video, role models play, and open discussion

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Ismail Dahshan, PhD · Suez Canal University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-03
Primary Completion
2020-05-17
Completion
2020-05-17

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05596305 on ClinicalTrials.gov